Repligen stock price
레플리젠NASDAQ:RGEN · Nasdaq · HealthcareToday's signals · No active technical signal.
Signal details →Repligen last closed at $181.70 (+2.52%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is 247.8×. Its overall grade ranks 194 of 739 stocks in Healthcare.
About this company
Repligen last closed at $181.70 (+2.52%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A- · 194/739
Valuation grade F
Related stocks
- Thermo Fisher ScientificCompetitor
바이오프로세싱·실험실 장비/소모품 분야의 주요 경쟁사
- DanaherCompetitor
생명과학 장비 및 바이오공정 솔루션에서 경쟁하는 대형 기업
- SartoriusCompetitor
바이오의약품 공정용 필터·장비·소모품에서 강한 경쟁사
ETFs holding this stock
Alger Mid Cap 40 ETF · First Trust NYSE Arca Biotechnology Index Fund · Invesco Dynamic BioTech & Genome ETF
Details →About Repligen
- What technical signals does Repligen (RGEN) have?
- Repligen current technical signals: no active technical signal.
- Is Repligen a cup-and-handle pattern?
- No. Repligen has no valid Cup signal right now.
- What published figures are available for Repligen?
- Market cap: $10.23B. Trailing 12 months PER: 247.8×. Latest quarter PBR: 4.87×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-03 dataset
Turn what you saw on this name into a strategy
Ask Q about Repligen, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).